What does MAPIALEJ do?

MAPIALEJ is a specialist medical practice in Overijse. Private Limited, started on 28 June 2019, 1 establishment.

What is the address of MAPIALEJ?

The registered office of MAPIALEJ is located at Drogenberg 20A, 3090 Overijse.

Is MAPIALEJ still active?

Yes. According to the CBE (15 November 2026) MAPIALEJ is active, legal situation “Normale toestand”, started on 28 June 2019.

Is MAPIALEJ registered on Peppol?

Yes, MAPIALEJ is registered on the Peppol network with ID 0208:0729570751.

What is the enterprise number of MAPIALEJ?

The enterprise number of MAPIALEJ is BE0729570751.

When was MAPIALEJ founded?

MAPIALEJ was founded on 28 June 2019.

Who are the directors of MAPIALEJ?

According to the 2025 annual accounts, the directors of MAPIALEJ are: Wendy FERNANDEZ VILLARREAL.

Is MAPIALEJ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 June 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did MAPIALEJ make in 2025?

MAPIALEJ posted a profit after taxes of € 265,405 in financial year 2025.

What is the revenue of MAPIALEJ?

As a small company, MAPIALEJ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 334,553.

MAPIALEJ (Private Limited) - Overijse - BE0729570751

Dossier MAPIALEJ, printed on 15 November 2026 from databakkes.be/en/0729570751/mapialej. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2025.

Financials

Financial year 2025

MAPIALEJ from Overijse, company number BE0729570751, closed financial year 2025 with a result of € 265,405 after tax. For that financial year MAPIALEJ recorded a gross margin of € 334,553 and equity of € 8,322. Compared with financial year 2024, the result moved from € 182,233 to € 265,405. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 10, 2026.

What it is worth Growing

€ 8,322

▲ € 6,822 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 265,405

▲ 46% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 106,933

▲ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 258,584 paid out

97 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 15,207

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go

€ 74,546

▲ 98% vs 2024

€ 31,111 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 76,117

▲ 239% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,017

▼ 42% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 150,847 Gross margin 2022: € 150,847 First fiscal year in the series	€ 152,288 Gross margin 2023: € 152,288 ▲ 1% vs 2022 (€ 150,847) Favourable step	€ 264,622 Gross margin 2024: € 264,622 ▲ 74% vs 2023 (€ 152,288) Favourable step	€ 334,553 Gross margin 2025: € 334,553 ▲ 26% vs 2024 (€ 264,622) Favourable step	▲ 26%
Profit after taxes	€ 109,420 Profit after taxes 2022: € 109,420 First fiscal year in the series	€ 94,367 Profit after taxes 2023: € 94,367 ▼ 14% vs 2022 (€ 109,420) Unfavourable step	€ 182,233 Profit after taxes 2024: € 182,233 ▲ 93% vs 2023 (€ 94,367) Favourable step	€ 265,405 Profit after taxes 2025: € 265,405 ▲ 46% vs 2024 (€ 182,233) Favourable step	▲ 46%
Equity	€ 1,500 Equity 2022: € 1,500 First fiscal year in the series	€ 1,500 Equity 2023: € 1,500 Unchanged (€ 1,500) Unchanged	€ 1,500 Equity 2024: € 1,500 Unchanged (€ 1,500) Unchanged	€ 8,322 Equity 2025: € 8,322 ▲ € 6,822 vs 2024 (€ 1,500) Favourable step	▲ € 6,822
Total debts	€ 156,659 Total debts 2022: € 156,659 First fiscal year in the series	€ 150,492 Total debts 2023: € 150,492 ▼ 4% vs 2022 (€ 156,659) Favourable step	€ 282,079 Total debts 2024: € 282,079 ▲ 87% vs 2023 (€ 150,492) Unfavourable step	€ 432,670 Total debts 2025: € 432,670 ▲ 53% vs 2024 (€ 282,079) Unfavourable step	▲ 53%
Cash	€ 63,162 Cash 2022: € 63,162 First fiscal year in the series	€ 29,110 Cash 2023: € 29,110 ▼ 54% vs 2022 (€ 63,162) Unfavourable step	€ 64,026 Cash 2024: € 64,026 ▲ 120% vs 2023 (€ 29,110) Favourable step	€ 106,933 Cash 2025: € 106,933 ▲ 67% vs 2024 (€ 64,026) Favourable step	▲ 67%
Retained profit	€ 0 Retained profit 2022: € 0 First fiscal year in the series	€ 0 Retained profit 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 6,822 Retained profit 2025: € 6,822 Unchanged (€ 0) Favourable step
Dividend	€ 109,420 Dividend 2022: € 109,420 First fiscal year in the series	€ 94,367 Dividend 2023: € 94,367 ▼ 14% vs 2022 (€ 109,420) Unchanged	€ 182,233 Dividend 2024: € 182,233 ▲ 93% vs 2023 (€ 94,367) Unchanged	€ 258,584 Dividend 2025: € 258,584 ▲ 42% vs 2024 (€ 182,233) Unchanged	▲ 42%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 14,583 Bank debt 2023: € 14,583 Unchanged (€ 0) Unfavourable step	€ 37,710 Bank debt 2024: € 37,710 ▲ 159% vs 2023 (€ 14,583) Unfavourable step	€ 74,546 Bank debt 2025: € 74,546 ▲ 98% vs 2024 (€ 37,710) Unfavourable step	▲ 98%
Balance sheet total	€ 158,159 Balance sheet total 2022: € 158,159 First fiscal year in the series	€ 151,992 Balance sheet total 2023: € 151,992 ▼ 4% vs 2022 (€ 158,159) Unchanged	€ 283,579 Balance sheet total 2024: € 283,579 ▲ 87% vs 2023 (€ 151,992) Unchanged	€ 440,991 Balance sheet total 2025: € 440,991 ▲ 56% vs 2024 (€ 283,579) Unchanged	▲ 56%

By gross margin, MAPIALEJ ranks 5th of 32 companies with main activity “Activiteiten van medisch specialisten” in Overijse that publish figures (fiscal year 2025).

Key figures of MAPIALEJ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

Ask about MAPIALEJ the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to MAPIALEJ?

What happened at MAPIALEJ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 10, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
Jul 2, 2019 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jun 28, 2019 New establishment in Beauvechain. KBO
2019 Wendy FERNANDEZ VILLARREAL became a director. NBB

In short

From € 109,420 profit in 2022 to € 265,405 profit in 2025.

Paid € 174,520 in corporate taxes since 2022.

Best year ever: 2025, with € 265,405 profit.

Paid out € 644,604 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Wendy FERNANDEZ VILLARREAL

MAPIALEJ

Behind MAPIALEJ is Wendy FERNANDEZ VILLARREAL.

Directors

According to the 2025 annual accounts

Wendy FERNANDEZ VILLARREAL

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Drogenberg 20A

3090 Overijse

2.293.142.851

Le Petit Champ, Nodebais 2

1320 Beauvechain

Active since 28 June 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Overijse

Same main activity (Activiteiten van medisch specialisten), 34 active companies in Overijse, largest first.

Beclinic

€ 1.9 million gross margin · 2025

DR. TESSA DE WANDELER RADIOLOGIE

€ 507,953 gross margin · 2025

BF Resp Oncology

€ 422,084 gross margin · 2025

GRANDJEAN FREDERIC DOCTEUR

€ 384,143 gross margin · 2025

Dr. Reynaert MDL

€ 293,636 gross margin · 2025

Pianite

€ 278,698 gross margin · 2025

All companies with this activity → Largest companies in Overijse →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

2 July 2019 Source: Deed ↗

FERNANDEZ VILLARREAL Wendy(oprichter) 100%

Details

Company number: 0729.570.751
VAT number: BE 0729.570.751
Registered office: Drogenberg 20A, 3090 Overijse
Names & denominations: MAPIALEJ
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 June 2019
Peppol: Active · Active since 24 Jun 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗